Document is current

Any future updates will be listed below

The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s10388-025-01162-3

Published Online: 2025-10-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark